SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63388 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61324The early AD diagnosis scenario is very important to the uptake of any drug, be scorman1-11/17/2022
61323I had cited a working hypothesis here that comes from Espay which contends &quoweatherproof111/17/2022
61322"Alas, this test isn't that. If they can figure out how to get more prerickerickson-11/17/2022
61321The better the ability to diagnose AD at early stages, the more valuable the druallatwwk-11/16/2022
61320Possible early detection of Alzheimer's. I'm catching up on my reading,erickerickson411/16/2022
61319stockdoc, that is exactly how I see it. Win the litigation and this thing is waallatwwk-11/16/2022
61318I think the stock is at fair value given its present sales, but if you think thestockdoc77-11/16/2022
61317SAVA m.thefly.comsysiphus-11/16/2022
61316I do think Lupkynis could be a $1billion product -- or more. But this is still eallatwwk-11/15/2022
61315Well 100 million is a lot, but it is a huge miss given the market cap of AUPH. stockdoc77-11/15/2022
61314As previously reported, on July 26, 2022 the U.S. Patent Office Patent Trial anallatwwk111/15/2022
61313wsw.commannamal211/15/2022
61312Investing in IBRX can be frustrating. They do not interact with the financial mamannamal211/15/2022
61311Allatwwk, I should know this and am too lazy to google it. In what court is theKeeptheFaith111/15/2022
61310stockdoc, On AUPH, I don't consider the product a flop. In fact, Lupkynis haallatwwk-11/15/2022
61309thank youplhky3465-11/15/2022
61308ANVS had some interesting trial data in their recent publication: Annovis Buntanscorman1-11/15/2022
61307I owned it for a while but sold at a small loss when initial sales were poor. Bistockdoc77211/15/2022
61306I have had a position for a while (bought at $13.00 ps!!!) Like the prospects. sysiphus-11/15/2022
61305Adding to the discussion on the roles of soluble vs. non-soluble a-beta in neuroweatherproof-11/15/2022
61304Anyone here invested in MRNS? I know Avoro has had a stake for a while, but sawIMMUzombie-11/15/2022
61303Yes, that hypothesis is coming from Espay. Two things to keep in mind: 1. As weatherproof-11/15/2022
61302Based on the unequivocal failure of the amyloid hypothesis, Neurologist/Biologisghettogoulash-11/14/2022
61301SAVA vs AVXL is simple and MOA is academic here.... the bottom line question is scorman1211/14/2022
61300SAVA case against shorts: Short sellers hit back at Cassava lawsuit against theerickerickson-11/14/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News